Graypoint LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$748K Sell
1,924
-304
-14% -$118K 0.04% 258
2025
Q1
$969K Buy
2,228
+658
+42% +$286K 0.06% 206
2024
Q4
$579K Sell
1,570
-1,161
-43% -$428K 0.04% 278
2024
Q3
$1.42M Buy
2,731
+256
+10% +$133K 0.09% 150
2024
Q2
$1.34M Buy
2,475
+247
+11% +$134K 0.09% 148
2024
Q1
$1.16M Buy
2,228
+247
+12% +$128K 0.08% 165
2023
Q4
$934K Buy
1,981
+297
+18% +$140K 0.08% 174
2023
Q3
$733K Buy
1,684
+193
+13% +$84K 0.07% 183
2023
Q2
$662K Sell
1,491
-124
-8% -$55.1K 0.07% 181
2023
Q1
$742K Buy
1,615
+536
+50% +$246K 0.08% 159
2022
Q4
$554K Sell
1,079
-6
-0.6% -$3.08K 0.07% 178
2022
Q3
$493K Buy
1,085
+358
+49% +$163K 0.06% 187
2022
Q2
$351K Buy
727
+258
+55% +$125K 0.05% 225
2022
Q1
$231K Buy
469
+31
+7% +$15.3K 0.02% 300
2021
Q4
$203K Buy
+438
New +$203K 0.02% 292